Growth hormone
Increase · large
Stimulates pituitary GH release
Literature evidence
Compound library
Vivy evidence dossier
Ipamorelin
Also indexed as Ipamorelin
T3Peptides
Read this entry as context, not instruction.
Evidence labels describe the material available in this reference entry. They do not establish that a compound is appropriate, effective, or safe for you. Inclusion is not a recommendation to use it.
Reference context
Pharmacokinetic context
Half-life2 hr
This field summarizes the library record. Half-life can vary with formulation, indication, and individual clinical context.
Observed relationships
Biomarker context
IGF-1
Increase · large
GH/IGF-1 axis activation
Literature evidence
IGFBP-3
Increase · moderate
GH-mediated binding proteins
Literature evidence
Keep in view
Safety discussion points
Ipamorelin is a selective Growth Hormone Secretagogue (GHS) and ghrelin analog. Promotes GH release with minimal cortisol or prolactin side effects. Not FDA-approved.
Keep the reference close
Track Ipamorelin in context.
Hey Vivy helps you organize protocols and review change over time. It does not diagnose, prescribe, or replace qualified care.